$CGNX

COGNEX CORP

No enriched coverage for $CGNX in the last 7 days.

No SEC Form 4 filings for $CGNX in the last 30 days.

High

Cognex OneVision™ Adoption Ramps as Manufacturers Scale AI Vision Globally

Cognex announced the general availability of OneVision™, its AI vision development environment, experiencing rapid adoption by manufacturers seeking to scale AI-powered inspection. The platform's cloud-to-edge architecture enables central management and deployment of AI models while ensuring real-time, edge-based inspection. Customers across various industries report faster development, improved throughput, and reduced costs, with examples from Essity, Schneider Electric, and 3M highlighting significant operational efficiencies.

Cognex chief legal officer Mark Fennell sells $4.3m in stock

Cognex Chief Legal Officer and Secretary Mark Fennell sold 64,873 shares of company common stock for approximately $4.35 million after exercising non-qualified stock options. The transactions occurred on May 11, 2026, and May 12, 2026, following which Fennell no longer directly holds common stock in Cognex. This significant sale comes after Cognex reported strong first-quarter 2026 results and a 114% stock return over the past year, though InvestingPro's fair value analysis suggests the stock might be overvalued.

UBS Group AG Cuts Stake in Cognex Corporation $CGNX

UBS Group AG significantly reduced its stake in Cognex Corporation by 39.3% in the fourth quarter, selling over 531,000 shares. Despite this, Cognex reported strong Q1 results, beating EPS and revenue estimates, and provided bullish Q2 guidance. Analysts have generally raised price targets, though some maintain a neutral outlook.